Ensem Therapeutics Competitors and Similar CompaniesClear all

Ensem Therapeutics's competitors and similar companies include AstraZeneca, Agenus, Fluxion Biosciences and Ecrins Therapeutics.

	Ensem Therapeutics Ensem Therapeutics is a drug discovery and development company focused on oncology.	AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.	Agenus Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.	Fluxion Biosciences Fluxion Biosciences is a company developing systems for live cell analysis.	Ecrins Therapeutics Ecrins Therapeutics is a biotechnology company that focuses on the discovery and development of anti-cancer compounds.
Founding Date	Founding Date 2021	Founding Date 1999	Founding Date 1994	Founding Date 2005	Founding Date 2010
Type	Type Private	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare artificial intelligence biotech clinical research drug development oncology	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology	Tags Healthcare biotech clinical research drug development oncology
Locations	Locations Waltham, US HQ Shanghai, CN	Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more	Locations Lexington, US HQ Cambridge, GB Emeryville, US Berkeley, US Vacaville, US	Locations Alameda, US HQ	Locations La Tronche, FR HQ
Employees	Employees 278% increase	Employees 94,300	Employees 8174% decrease	Employees 7	Employees 1
Valuation ($)	Valuation ($) N/A	Valuation ($) 2.7 b	Valuation ($) 96.2 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $58.7b (FY, 2025)	Revenue (est.) $114.2m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $4.9b (FY, 2025)	Cost of goods $1m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $54.2b (FY, 2025)	Gross profit $113.2m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income $10.2b (FY, 2025)	Net income ($3.1m) (FY, 2025)	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round $ 67m (about 4 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 280k (over 6 years ago)	Latest funding round $ 599.1k (almost 11 years ago)
Total funding raised	Total funding raised $ 67m	Total funding raised $ 1b	Total funding raised $ 171.1m	Total funding raised $ 22.5m	Total funding raised $ 2.7m